Dhampur Bio Organics shareholders approve dividend, CEO redesignation at AGM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Dhampur Bio Organics Limited concluded its 6th AGM with unanimous promoter support for all resolutions, including a ₹1.50 dividend and leadership restructuring. The meeting addressed financial statements, auditor appointments, and governance amendments, reflecting strong shareholder alignment despite minor public dissent on specific structural changes.

powered bylight_fuzz_icon
46586594

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics Limited shareholders approved a final dividend of ₹1.50 per equity share and re-designated Gautam Goel as Chairman and CEO during its 6th Annual General Meeting held on July 24, 2026. The meeting, conducted via video conferencing, saw the passage of all 11 resolutions with overwhelming support from promoter groups, solidifying governance changes following the slump sale of the Meerganj unit.

The meeting commenced at 4:00 PM IST with a quorum present through virtual attendance. Saket Sharma of M/s GSK & Associates served as the scrutinizer, submitting his consolidated report on July 25, 2026. The statutory auditors, M/s Mittal Gupta & Company, were re-appointed for a second five-year term. Remote e-voting was active from July 20 to July 23, 2026, while e-voting at the AGM allowed additional participation for those who had not voted remotely.

Key Resolutions Passed

Shareholders voted on four ordinary business items and seven special business items. All resolutions received majority approval, driven by near-unanimous support from the promoter group.

Resolution Type Particulars Status
Ordinary Adoption of Audited Financial Statements for FY26 Passed
Ordinary Declaration of final dividend @15% (₹1.50 per share) Passed
Ordinary Re-appointment of Gautam Goel as Director Passed
Ordinary Re-appointment of Statutory Auditors for 5 years Passed
Special Amendment of Articles of Association (Article 125A) Passed
Special Re-designation of Gautam Goel as Chairman and CEO Passed
Special Amendment in gratuity payment terms for Directors Passed
Ordinary Revision in remuneration of Maayashree Goel Passed
Ordinary Revision in remuneration of Meerashree Goel Passed
Special Payment of Commission to Non-Executive Directors Passed
Ordinary Ratification of Cost Auditor remuneration for FY27 Passed

Voting Analysis

Promoter and Promoter Group shareholders, holding 33,714,207 shares, cast 99.74% of their eligible votes. They voted in favor of all resolutions except for the re-appointment of Gautam Goel by rotation and his re-designation as CEO, where participation was lower but still resulted in unanimous support among votes cast. Public non-institutional shareholders showed dissent on specific governance changes; approximately 4.27% voted against the AOA amendment, while 4.54% opposed the CEO re-designation. However, these dissenting votes did not impact the passage of any resolution.

Governance Updates

The special resolution to amend the Articles of Association by inserting new Article 125A passed with 99.99% support. Additionally, shareholders approved amendments to the terms of gratuity payment to directors, which received 99.86% support. The remuneration revisions for General Managers Maayashree Goel and Meerashree Goel were also approved, each garnering 99.89% support. The company ratified the payment of commission to non-executive directors for FY26, passing with 99.99% approval.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.29%+11.37%+21.99%+34.35%+44.49%-21.98%

How will the integration of the Meerganj unit post-slump sale impact Dhampur Bio Organics' operational efficiency and EBITDA margins in FY27?

What is the strategic rationale behind the amendment to Article 125A of the Articles of Association, and how might it alter future corporate governance structures?

Given the revision in remuneration for General Managers Maayashree Goel and Meerashree Goel, what specific performance metrics or expansion targets are expected to justify these increases?

Dhampur Bio Organics profit rises on unit sale in Q1FY27

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Dhampur Bio Organics reported a consolidated net profit of ₹36.79 crore for Q1FY27, reversing a net loss of ₹22 crore in the same period last year, primarily due to a one-time gain of ₹63.89 crore from the sale of its Meerganj manufacturing unit. Consolidated revenue from operations increased to ₹918.56 crore from ₹750.64 crore, while standalone revenue net of excise grew 4.51% to ₹553.88 crore. The Country Liquor segment led revenue growth, and the company reduced its long-term debt by ₹93 crore during the quarter.

powered bylight_fuzz_icon
45559261

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics reported a consolidated net profit of ₹36.79 crore for the quarter ended June 30, 2026, a significant turnaround from the net loss of ₹22 crore in the corresponding period of the previous year. This recovery was driven by a one-time gain from the sale of a manufacturing unit and robust revenue growth across its continuing operations. The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter on July 14, 2026.

Financial Performance

The company's consolidated revenue from operations for Q1FY27 stood at ₹918.56 crore, up from ₹750.64 crore in the same quarter last year. Total income from operations, including other income, rose to ₹919.77 crore. On a standalone basis, revenue from operations increased to ₹939.55 crore from ₹788.15 crore in the previous year.

A key factor contributing to the profitability was the gain from the sale of the Meerganj sugar manufacturing unit. The company sold the undertaking on a slump sale basis for an aggregate consideration of ₹305 crore, resulting in a gain of ₹63.89 crore. This operation has been classified as discontinued operations.

Metric (Consolidated) Q1FY27 (₹ in Crore) Q1FY26 (₹ in Crore)
Revenue from Operations 918.56 750.64
Total Income 919.77 752.13
Net Profit 36.79 (22.00)

Segment and Operational Details

The company operates across three main segments: Sugar, Bio Fuels & Spirits, and Country Liquor. The Country Liquor segment was the top revenue contributor, generating ₹489.08 crore in the quarter. The Sugar segment reported revenue of ₹371.32 crore, while Bio Fuels & Spirits contributed ₹80.78 crore.

The Board also approved the appointment of M/s Grant Thornton Bharat LLP as the Internal Auditor for the financial year 2026-27. The statutory auditors, Mittal Gupta & Co., performed a limited review of the unaudited financial results and issued an unmodified conclusion. The company noted that sugar is a seasonal industry, and quarterly performance may not be representative of the annual results.

Investor Presentation Highlights

According to the investor presentation for Q1FY27, standalone revenue net of excise was ₹553.88 crore, a 4.51% year-on-year increase. EBITDA stood at ₹12.28 crore with a margin of 2.22%. Profit after tax (PAT) for the quarter was ₹38.40 crore, which includes the gain from discontinued operations. The company repaid long-term loans of ₹93 crore during the quarter, reducing long-term debt to ₹197 crore as on June 30, 2026.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.29%+11.37%+21.99%+34.35%+44.49%-21.98%

How will the sale of the Meerganj unit impact Dhampur Bio Organics' future production capacity and operational strategy?

What are the company's plans for utilizing the proceeds from the ₹305 crore sale of the manufacturing unit?

Will the company continue to reduce its long-term debt, or are there plans for reinvestment in core segments?

More News on Dhampur Bio Organics

1 Year Returns:+44.49%